Venkataraman Balasubramanian

Array ( [id] => 5230859 [patent_doc_number] => 20070292967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Assay for Ligands of the Ecdysone Receptor' [patent_app_type] => utility [patent_app_number] => 10/596154 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15929 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20070292967.pdf [firstpage_image] =>[orig_patent_app_number] => 10596154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705725 [patent_doc_number] => 20060194773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Tetracyline compounds having target therapeutic activities' [patent_app_type] => utility [patent_app_number] => 10/996119 [patent_app_country] => US [patent_app_date] => 2004-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31783 [patent_no_of_claims] => 132 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194773.pdf [firstpage_image] =>[orig_patent_app_number] => 10996119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748401 [patent_doc_number] => 20060111333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Structural, behavioral characterization, and synthesis of attractants for migratory lamprey' [patent_app_type] => utility [patent_app_number] => 10/993802 [patent_app_country] => US [patent_app_date] => 2004-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11011 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111333.pdf [firstpage_image] =>[orig_patent_app_number] => 10993802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120663 [patent_doc_number] => 20070142378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Method of treating restless legs syndrome and/or periodic limb movement disorder with (2s,3s) 2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol' [patent_app_type] => utility [patent_app_number] => 10/595885 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5427 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142378.pdf [firstpage_image] =>[orig_patent_app_number] => 10595885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912934 [patent_doc_number] => 20050176692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Oral androgen therapy using modulators of testosterone bioavailability' [patent_app_type] => utility [patent_app_number] => 10/990118 [patent_app_country] => US [patent_app_date] => 2004-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15989 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176692.pdf [firstpage_image] =>[orig_patent_app_number] => 10990118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7187997 [patent_doc_number] => 20050192263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Novel 17beta-hydroxysteroid dehydrogenase type I inhibitors' [patent_app_type] => utility [patent_app_number] => 10/983887 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53226 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192263.pdf [firstpage_image] =>[orig_patent_app_number] => 10983887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6959400 [patent_doc_number] => 20050215532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Tetracycline compounds for treatment of cryptosporidium parvum related disorders' [patent_app_type] => utility [patent_app_number] => 10/982728 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7361 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215532.pdf [firstpage_image] =>[orig_patent_app_number] => 10982728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 500959 [patent_doc_number] => 07205287 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-17 [patent_title] => 'Platinum complexes having antitumor activity' [patent_app_type] => utility [patent_app_number] => 10/971900 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1703 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/205/07205287.pdf [firstpage_image] =>[orig_patent_app_number] => 10971900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075518 [patent_doc_number] => 20050148786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Diimmonium compound and use thereof' [patent_app_type] => utility [patent_app_number] => 10/971777 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10799 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148786.pdf [firstpage_image] =>[orig_patent_app_number] => 10971777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 888197 [patent_doc_number] => 07348320 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-25 [patent_title] => 'Platinum complexes containing chemically modified bile acids, having antitumor activity' [patent_app_type] => utility [patent_app_number] => 10/970484 [patent_app_country] => US [patent_app_date] => 2004-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2616 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/348/07348320.pdf [firstpage_image] =>[orig_patent_app_number] => 10970484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991638 [patent_doc_number] => 20050090675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Process for preparing highly pure androstane 17-beta-carboxylic acids and 17-beta-carbothioic acid fluoromethyl esters thereof' [patent_app_type] => utility [patent_app_number] => 10/969241 [patent_app_country] => US [patent_app_date] => 2004-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3316 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090675.pdf [firstpage_image] =>[orig_patent_app_number] => 10969241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4734402 [patent_doc_number] => 20080051382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Crystalline Forms of 3-Beta-Amino 17-Methylene Androstane-6-Alpha 7-Beta-Diol Hydrochloride' [patent_app_type] => utility [patent_app_number] => 10/575689 [patent_app_country] => US [patent_app_date] => 2004-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2408 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051382.pdf [firstpage_image] =>[orig_patent_app_number] => 10575689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5794048 [patent_doc_number] => 20060014729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Compounds and their preparation for the treatment of Alzheimer\'s disease by inhibiting beta-amyloid peptide production' [patent_app_type] => utility [patent_app_number] => 10/963214 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14102 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014729.pdf [firstpage_image] =>[orig_patent_app_number] => 10963214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5794023 [patent_doc_number] => 20060014704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Compounds and their preparation for the treatment of Alzheimer\'s disease by inhibiting beta-amyloid peptide production' [patent_app_type] => utility [patent_app_number] => 10/961346 [patent_app_country] => US [patent_app_date] => 2004-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12038 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014704.pdf [firstpage_image] =>[orig_patent_app_number] => 10961346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206510 [patent_doc_number] => 20050043281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => '2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds' [patent_app_type] => utility [patent_app_number] => 10/957483 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7979 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043281.pdf [firstpage_image] =>[orig_patent_app_number] => 10957483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075293 [patent_doc_number] => 20050148561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Novel triterpene derivatives, preparation thereof and use thereof' [patent_app_type] => utility [patent_app_number] => 10/949875 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8285 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148561.pdf [firstpage_image] =>[orig_patent_app_number] => 10949875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 612816 [patent_doc_number] => 07148213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-12 [patent_title] => 'Antigestagenically active steroids with a fluorinated 17α-alkyl chain' [patent_app_type] => utility [patent_app_number] => 10/948652 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10307 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/148/07148213.pdf [firstpage_image] =>[orig_patent_app_number] => 10948652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7255035 [patent_doc_number] => 20050075321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Neurological disorder treatment methods' [patent_app_type] => utility [patent_app_number] => 10/949782 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 112223 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075321.pdf [firstpage_image] =>[orig_patent_app_number] => 10949782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7233414 [patent_doc_number] => 20050256095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Asthma and colitis treatment methods' [patent_app_type] => utility [patent_app_number] => 10/949694 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 112305 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256095.pdf [firstpage_image] =>[orig_patent_app_number] => 10949694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972560 [patent_doc_number] => 20050038270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Methods for producing sterol ester-rich compositions' [patent_app_type] => utility [patent_app_number] => 10/946674 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3594 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038270.pdf [firstpage_image] =>[orig_patent_app_number] => 10946674 [rel_patent_id] =>[rel_patent_doc_number] =>)